These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6627200)

  • 1. Enuresis: a new look at stimulant therapy.
    Diamond JM; Stein JM
    Can J Psychiatry; 1983 Aug; 28(5):395-7. PubMed ID: 6627200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine Alleviates Stimulant Dysphoria, Helps With Enuresis, and Complements Cognitive Response in an Adolescent With Attention-Deficit/Hyperactivity Disorder.
    Naguy A
    Prim Care Companion CNS Disord; 2016 Dec; 18(6):. PubMed ID: 28033457
    [No Abstract]   [Full Text] [Related]  

  • 3. Add-on Milnacipran Boosts Methylphenidate Response in an Adolescent With Attention-Deficit/Hyperactivity Disorder With Comorbid Anxiety and Enuresis.
    Naguy A; Elsori DH; AlAwadhi DS; Alamiri B
    Am J Ther; 2019; 26(6):e730-e732. PubMed ID: 31567150
    [No Abstract]   [Full Text] [Related]  

  • 4. Imipramine treatment of ADHD in a fragile X child.
    Hilton DK; Martin CA; Heffron WM; Hall BD; Johnson GL
    J Am Acad Child Adolesc Psychiatry; 1991 Sep; 30(5):831-4. PubMed ID: 1938802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atomoxetine for the treatment of pediatric nocturnal enuresis.
    Shatkin JP
    J Child Adolesc Psychopharmacol; 2004; 14(3):443-7. PubMed ID: 15650501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipramine in the treatment of minimal brain dysfunction in children.
    Gross MD
    Psychosomatics; 1973; 14(5):283-5. PubMed ID: 4794958
    [No Abstract]   [Full Text] [Related]  

  • 7. Does stimulant medication improve the peer status of hyperactive children?
    Whalen CK; Henker B; Buhrmester D; Hinshaw SP; Huber A; Laski K
    J Consult Clin Psychol; 1989 Aug; 57(4):545-9. PubMed ID: 2768616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
    Bricard C; Boidein F
    Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stimulant medication and the hyperactive adolescent: myths and facts.
    Clampit MK; Pirkle JB
    Adolescence; 1983; 18(72):811-22. PubMed ID: 6666706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylphenidate-associated enuresis in attention deficit hyperactivity disorder.
    Ghanizadeh A
    J Pediatr Urol; 2008 Aug; 4(4):306-7. PubMed ID: 18644535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperactive girls and boys: stimulant drug effects on mother-child interactions.
    Barkley RA
    J Child Psychol Psychiatry; 1989 May; 30(3):379-90. PubMed ID: 2663900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The speech of hyperactive children and their mothers: comparison with normal children and stimulant drug effects.
    Barkley RA; Cunningham CE; Karlsson J
    J Learn Disabil; 1983 Feb; 16(2):105-10. PubMed ID: 6842069
    [No Abstract]   [Full Text] [Related]  

  • 14. [Methylphenidate and sleep: Results of a multicentre study on a population of children with attention deficit hyperactivity disorder].
    Tomás Vila M; Aleu Pérez-Gramunt M; Beseler Soto B; Benac Prefasi M; Pantoja Martínez J; Pitarch Castellano I
    An Pediatr (Barc); 2010 Aug; 73(2):78-83. PubMed ID: 20605120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety and methylphenidate in attention deficit hyperactivity disorder: a double-blind placebo-drug trial.
    Moshe K; Karni A; Tirosh E
    Atten Defic Hyperact Disord; 2012 Sep; 4(3):153-8. PubMed ID: 22622628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
    Pae CU
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
    [No Abstract]   [Full Text] [Related]  

  • 17. Classroom social interactions of attention deficit disorder with hyperactivity children as a function of stimulant medication.
    Wallander JL; Schroeder SR; Michelli JA; Gualtieri CT
    J Pediatr Psychol; 1987 Mar; 12(1):61-76. PubMed ID: 3553519
    [No Abstract]   [Full Text] [Related]  

  • 18. Rate dependency revisited: understanding the effects of methylphenidate in children with attention deficit hyperactivity disorder.
    Teicher MH; Polcari A; Anderson CM; Andersen SL; Lowen SB; Navalta CP
    J Child Adolesc Psychopharmacol; 2003; 13(1):41-51. PubMed ID: 12804125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. School observations of children with attention-deficit hyperactivity disorder and comorbid tic disorder: effects of methylphenidate treatment.
    Gadow KD; Nolan E; Sprafkin J; Sverd J
    J Dev Behav Pediatr; 1995 Jun; 16(3):167-76. PubMed ID: 7560119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effects of a controlled trial of methylphenidate on adolescents with attention deficit disorder.
    Klorman R; Brumaghim JT; Fitzpatrick PA; Borgstedt AD
    J Am Acad Child Adolesc Psychiatry; 1990 Sep; 29(5):702-9. PubMed ID: 2228922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.